Care of the human immunodeficiency virus-infected menopausal woman

Am J Obstet Gynecol. 2012 Aug;207(2):87-93. doi: 10.1016/j.ajog.2011.12.031. Epub 2011 Dec 30.

Abstract

More women than ever before are both human immunodeficiency virus infected and menopausal, because of increased survival and more frequent diagnosis in older women. Such a woman has the combined burden of her infection, its treatment, comorbid conditions, and aging. Thus, she is at risk for a variety of problems, such as disorders of bone mineral density and deficiencies in cognitive functioning. In addition to this, she experiences menopause in a unique fashion, with more symptoms and perhaps at an earlier age. The clinician caring for her must take a proactive approach to this multitude of factors that may affect her health and well-being.

Publication types

  • Review

MeSH terms

  • Aging / physiology
  • Anti-Retroviral Agents / adverse effects
  • Bone Density / physiology
  • Bone Diseases, Metabolic / diagnosis
  • Bone Diseases, Metabolic / etiology
  • Bone Diseases, Metabolic / physiopathology
  • Cognition Disorders / etiology
  • Cognition Disorders / physiopathology
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / physiopathology*
  • HIV Seropositivity
  • Hippocampus / physiopathology
  • Humans
  • Mass Screening
  • Menopause / physiology*
  • Practice Guidelines as Topic
  • Risk Factors
  • Sexually Transmitted Diseases / complications
  • Sexually Transmitted Diseases / diagnosis
  • Uterine Cervical Neoplasms / diagnosis

Substances

  • Anti-Retroviral Agents